Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (121-130 of 307) with videos related to

Pageof 31
Sort By:
The Journal of Urology|November 3, 2015
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal TumorsTakahiro Osawa, Khaled S Hafez, David C Miller, et al.
Medical Care|November 8, 2016
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry DataMarc C Smaldone, Brian Egleston, John M Hollingsworth, et al.
Urology|April 26, 2022
Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case SeriesSteven B Goldenthal, Melissa A Reimers, Udit Singhal, et al.
Plos One|January 26, 2016
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood SamplesPriya Gogoi, Saedeh Sepehri, Yi Zhou, et al.
Contemporary Clinical Trials|October 21, 2021
Prostate cancer clinical trial completion: The role of geographyKristian D Stensland, Samuel D Kaffenberger, Arvin K George, et al.
European Urology Oncology|July 9, 2023
The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing LiteratureAkshay Sood, Amar U Kishan, Christopher P Evans, et al.
Human Pathology|December 13, 2022
Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platformsErica Vormittag-Nocito, Rahul Mannan, Xiaoming Wang, et al.
JCO Precision Oncology|May 29, 2024
Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell CarcinomaRohit Mehra, Srinivas Nallandhighal, Brittney Cotta, et al.
Photoacoustics|November 17, 2022
Assessment of prostate cancer progression using a translational needle photoacoustic sensing probe: Preliminary study with intact human prostates <i>ex-vivo</i>Linyu Ni, Wei-Kuan Lin, Amy Kasputis, et al.
Radiation Oncology (London, England)|July 10, 2013
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyWilliam C Jackson, Skyler B Johnson, Darren Li, et al.
Pageof 31

Showing results (121-130 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Urology|November 3, 2015
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal TumorsTakahiro Osawa, Khaled S Hafez, David C Miller, et al.
Medical Care|November 8, 2016
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry DataMarc C Smaldone, Brian Egleston, John M Hollingsworth, et al.
Urology|April 26, 2022
Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case SeriesSteven B Goldenthal, Melissa A Reimers, Udit Singhal, et al.
Plos One|January 26, 2016
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood SamplesPriya Gogoi, Saedeh Sepehri, Yi Zhou, et al.
Contemporary Clinical Trials|October 21, 2021
Prostate cancer clinical trial completion: The role of geographyKristian D Stensland, Samuel D Kaffenberger, Arvin K George, et al.
European Urology Oncology|July 9, 2023
The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing LiteratureAkshay Sood, Amar U Kishan, Christopher P Evans, et al.
Human Pathology|December 13, 2022
Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platformsErica Vormittag-Nocito, Rahul Mannan, Xiaoming Wang, et al.
JCO Precision Oncology|May 29, 2024
Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell CarcinomaRohit Mehra, Srinivas Nallandhighal, Brittney Cotta, et al.
Photoacoustics|November 17, 2022
Assessment of prostate cancer progression using a translational needle photoacoustic sensing probe: Preliminary study with intact human prostates <i>ex-vivo</i>Linyu Ni, Wei-Kuan Lin, Amy Kasputis, et al.
Radiation Oncology (London, England)|July 10, 2013
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyWilliam C Jackson, Skyler B Johnson, Darren Li, et al.
Pageof 31